Barclays Boosts Elevance Health (NYSE:ELV) Price Target to $522.00
Elevance Health (NYSE:ELV – Free Report) had its price objective increased by Barclays from $512.00 to $522.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an overweight rating on the stock. Several other research analysts have also recently weighed in on ELV. Guggenheim began coverage on Elevance Health in a report on […]
Elevance Health (NYSE:ELV – Free Report) had its price objective increased by Barclays from $512.00 to $522.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an overweight rating on the stock. Several other research analysts have also recently weighed in on ELV. Guggenheim began coverage on Elevance Health in a report on […]
